novartis hits acquisition trail swiss drugmaker novartis has announced 5.65bn euros 7.4bn 3.9bn of purchases to make its sandoz unit the world's biggest generic drug producer.novartis, which last month forecast record sales for 2005, said it had bought all of germany's hexal.novartis said that it would be able to make cost savings of about 200m a year following the acquisitions.the deal will see novartis' sandoz business overtake israel's teva pharmaceuticals as the world's biggest maker of generics.novartis said that it would merge a number of departments, adding that there may be job cuts.there are more than 150 generic drugmakers worldwide and analysts have predicted consolidation in a market that they call fragmented.